BrightSpring Health Services (NASDAQ:BTSG) Announces Earnings Results, Misses Estimates By $0.02 EPS

BrightSpring Health Services (NASDAQ:BTSG) issued its quarterly earnings results on Thursday. The company reported $0.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.02), Zacks reports. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%.

BrightSpring Health Services Stock Down 4.1 %

BTSG stock traded down $0.76 during midday trading on Thursday, reaching $17.63. 1,728,790 shares of the company were exchanged, compared to its average volume of 1,496,737. The company has a market cap of $3.07 billion and a price-to-earnings ratio of -67.48. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. BrightSpring Health Services has a 1-year low of $7.85 and a 1-year high of $24.82. The stock’s 50-day simple moving average is $20.04 and its 200 day simple moving average is $17.45.

Wall Street Analyst Weigh In

BTSG has been the topic of several recent research reports. Morgan Stanley upped their target price on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. UBS Group boosted their target price on BrightSpring Health Services from $22.00 to $30.00 and gave the stock a “buy” rating in a research note on Wednesday, January 29th. Wells Fargo & Company increased their price target on BrightSpring Health Services from $17.00 to $21.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. CJS Securities began coverage on BrightSpring Health Services in a research report on Thursday, December 12th. They set an “outperform” rating and a $27.00 price objective for the company. Finally, Bank of America raised their target price on shares of BrightSpring Health Services from $19.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, BrightSpring Health Services presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.80.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.